Associations Between Statin Treatment and Markers of Inflammation, Vasoconstriction, and Coagulation in Patients With Abdominal Aortic Aneurysm

Anders Gottsäter, Despina Flondell-Sité, Tilo Kölbel, Bengt Lindblad

Research output: Contribution to journalArticlepeer-review

Abstract

The association of statins with markers of inflammation, vasoconstriction, and coagulation was evaluated in 325 patients with abdominal aortic aneurysm with respect to statin treatment or not. Variables evaluated included routine laboratory markers, lipids, homocysteine, endothelin-1, matrix metalloproteinases (MMP)-2 and -9, and activated protein C-protein C inhibitor (APC-PCI) complex. Statin-treated patients were more often male (85% vs 75%; P = .024) and had ischemic heart disease (57% vs 19%; P < .0001). They showed lower levels of cholesterol (P < .0001), homocysteine (P = .027), MMP-9 (P = .038), and endothelin-1 (P = .005), and higher levels of APC-PCI complex (P = .042). Differences persisted in logistic regression for cholesterol (P < .0001), APC-PCI complex (P = .034), and homocysteine (P = .021). Statin-treated patients with abdominal aortic aneurysm show higher APC-PCI complex and lower homocysteine levels. Whether this translates into lower risk for aneurysm expansion or rupture will be evident from further follow-up.
Original languageEnglish
Pages (from-to)567-573
JournalVascular and Endovascular Surgery
Volume42
Issue number6
DOIs
Publication statusPublished - 2008

Subject classification (UKÄ)

  • Cardiac and Cardiovascular Systems

Free keywords

  • homocysteine
  • inflammation
  • abdominal aortic aneurysm
  • statins
  • APC-PCI
  • complex

Fingerprint

Dive into the research topics of 'Associations Between Statin Treatment and Markers of Inflammation, Vasoconstriction, and Coagulation in Patients With Abdominal Aortic Aneurysm'. Together they form a unique fingerprint.

Cite this